Keyphrases
Virus
100%
Yellow Fever
83%
West Nile Virus
76%
Flavivirus
41%
Japanese Encephalitis Virus
32%
Envelope Protein
31%
Virus Strains
26%
Attenuation
22%
Yellow Fever Vaccine
22%
Monoclonal Antibody
22%
Dengue Virus
22%
Vaccine Virus
22%
Genotype
20%
Vaccine Development
20%
Epitope
18%
Zika Virus
18%
Dengue
18%
17D Vaccine
18%
North America
17%
Envelope Protein Domain III
16%
Virus Isolate
16%
Virus Envelope
15%
E Protein
14%
Live Attenuated Vaccine
13%
Nucleotide Sequence
13%
Recombinant
13%
Live Attenuated
13%
Virulence
12%
Immunogenicity
12%
Vaccine Strain
12%
NS4B
12%
Viscerotropic Disease
11%
Type-specific
11%
Neurovirulence
11%
Neutralizing Antibodies
11%
Zika Vaccine
10%
Defective Interfering
10%
AG129 Mice
10%
Semliki Forest Virus
10%
Virus Vaccine
10%
Japanese Encephalitis
10%
Mouse Model
10%
Amino Acid Substitution
9%
Africa
9%
South America
9%
Amino Acids
9%
Amino Acid Sequence
9%
Tick-borne Flavivirus
9%
Immune Response
9%
Vaccine Candidate
9%
Immunology and Microbiology
West Nile Virus
68%
Yellow Fever Virus
56%
Flavivirus
39%
Wild Type
37%
Yellow Fever
35%
Japanese Encephalitis Virus Group
32%
Japanese Encephalitis Virus
32%
Epitope
27%
Monoclonal Antibody
24%
Virus Strain
24%
Dengue Virus
24%
Viral Disease
21%
Yellow Fever Vaccine
21%
Virus Vaccine
20%
Dengue Fever
20%
Immunology
19%
Neutralization
18%
Attenuated Vaccine
18%
Live Vaccine
18%
Protein Tertiary Structure
16%
Viral Envelope
15%
Neutralizing Antibody
15%
NS4B
14%
Cladistics
13%
Zika Virus
13%
Dengue Virus 2
12%
Amino Acid Substitution
12%
Mouse Model
11%
Immune Response
11%
Semliki Forest Virus
10%
Immunogenicity
10%
Nucleotide Sequence
10%
Encephalitis
10%
Viremia
9%
Japanese Encephalitis
9%
Virus Mutant
9%
Japanese Encephalitis Vaccine
9%
Genetic Variability
9%
Hemorrhagic Fever
8%
Haplorhini
8%
Infectious Agent
8%
Defective Interfering Particle
8%
Adoptive Immunity
8%
T Cell
8%
Glycosylation
8%
Lineages
8%
Tick Borne Flavivirus
7%
Type Strain
7%
Amino Acid Sequence
6%
Dengue Vaccine
6%